Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Account Payables (2016 - 2026)

Viridian Therapeutics, Inc.\DE has reported Change in Account Payables over the past 10 years, most recently at -$1.4 million for Q4 2025.

  • Quarterly results put Change in Account Payables at -$1.4 million for Q4 2025, up 64.82% from a year ago — trailing twelve months through Dec 2025 was $6.6 million (up 9089.04% YoY), and the annual figure for FY2025 was $6.6 million, up 9089.04%.
  • Change in Account Payables for Q4 2025 was -$1.4 million at Viridian Therapeutics, Inc.\DE, down from $1.5 million in the prior quarter.
  • Over the last five years, Change in Account Payables for VRDN hit a ceiling of $8.0 million in Q3 2022 and a floor of -$6.6 million in Q1 2023.
  • Median Change in Account Payables over the past 5 years was $460000.0 (2024), compared with a mean of $381400.0.
  • Biggest five-year swings in Change in Account Payables: plummeted 21541.94% in 2023 and later skyrocketed 2812.96% in 2024.
  • Viridian Therapeutics, Inc.\DE's Change in Account Payables stood at -$1.4 million in 2021, then soared by 224.11% to $1.7 million in 2022, then crashed by 186.88% to -$1.5 million in 2023, then crashed by 158.77% to -$3.9 million in 2024, then surged by 64.82% to -$1.4 million in 2025.
  • The last three reported values for Change in Account Payables were -$1.4 million (Q4 2025), $1.5 million (Q3 2025), and $4.6 million (Q2 2025) per Business Quant data.